Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Daly

Showing results (51-60 of 472) with videos related to

Pageof 48
Sort By:
Expert Review of Anticancer Therapy|July 13, 2002
Pharmacogenetics of cytotoxic drugsA K Daly, A G Hall
Expert Opinion on Drug Metabolism & Toxicology|July 26, 2006
Contribution of CYP2C9 to variability in vitamin K antagonist metabolismAnn K Daly, Barry P King
Pharmacogenetics|May 2, 2003
Pharmacogenetics of oral anticoagulantsAnn K Daly, Barry P King
Biochemical Pharmacology|June 30, 2000
Identification of human cytochrome P450 isoforms that contribute to all-trans-retinoic acid 4-hydroxylationL C McSorley, A K Daly
British Journal of Clinical Pharmacology|December 12, 2001
Candidate gene case-control association studies: advantages and potential pitfallsA K Daly, C P Day
Environmental Health Perspectives|October 1, 1993
New opportunities in cancer risk evaluation using PCR-based DNA analysis for CYP2D6J R Idle, A K Daly
Insight (American Society of Ophthalmic Registered Nurses)|June 16, 2010
Indications and care of keratoprosthesis patientsTulay Cakiner-Egilmez, Mary K Daly
The Journal of Bone and Joint Surgery. British Volume|June 29, 2000
Lateral shelf acetabuloplasty in Perthes' disease. A review of the end of growthK Daly, C Bruce, A Catterall
Nature Genetics|July 29, 2010
Preempting and preventing drug-induced liver injuryGuruprasad P Aithal, Ann K Daly
Seminars in Liver Disease|October 15, 2009
Genetic association studies in drug-induced liver injuryAnn K Daly, Chris P Day
Pageof 48

Showing results (51-60 of 472) with videos related to

Sort By:
Pageof 48
Expert Review of Anticancer Therapy|July 13, 2002
Pharmacogenetics of cytotoxic drugsA K Daly, A G Hall
Expert Opinion on Drug Metabolism & Toxicology|July 26, 2006
Contribution of CYP2C9 to variability in vitamin K antagonist metabolismAnn K Daly, Barry P King
Pharmacogenetics|May 2, 2003
Pharmacogenetics of oral anticoagulantsAnn K Daly, Barry P King
Biochemical Pharmacology|June 30, 2000
Identification of human cytochrome P450 isoforms that contribute to all-trans-retinoic acid 4-hydroxylationL C McSorley, A K Daly
British Journal of Clinical Pharmacology|December 12, 2001
Candidate gene case-control association studies: advantages and potential pitfallsA K Daly, C P Day
Environmental Health Perspectives|October 1, 1993
New opportunities in cancer risk evaluation using PCR-based DNA analysis for CYP2D6J R Idle, A K Daly
Insight (American Society of Ophthalmic Registered Nurses)|June 16, 2010
Indications and care of keratoprosthesis patientsTulay Cakiner-Egilmez, Mary K Daly
The Journal of Bone and Joint Surgery. British Volume|June 29, 2000
Lateral shelf acetabuloplasty in Perthes' disease. A review of the end of growthK Daly, C Bruce, A Catterall
Nature Genetics|July 29, 2010
Preempting and preventing drug-induced liver injuryGuruprasad P Aithal, Ann K Daly
Seminars in Liver Disease|October 15, 2009
Genetic association studies in drug-induced liver injuryAnn K Daly, Chris P Day
Pageof 48